IL-8 Reduced Tumorigenicity of Human Ovarian Cancer In Vivo Due to Neutrophil Infiltration
Open Access
- 1 March 2000
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 164 (5) , 2769-2775
Abstract
Paclitaxel is a frontline therapy for ovarian cancer. Our laboratory has shown that paclitaxel induces IL-8, a member of the C-X-C family of chemokines, in subsets of human ovarian cancer cells. However, the critical issue concerns the biological significance of this chemokine in human ovarian cancer. To study the influence of IL-8 on tumor growth, human ovarian cancer cell lines were transfected with an expression vector for human IL-8 and tested for their ability to form tumors in nude mice. IL-8 expression by the transfected cells did not alter their growth properties in vitro. In contrast, tumor growth in vivo was significantly attenuated in animals receiving IL-8-expressing cells when compared with mice injected with control cells. As additional evidence that IL-8 is a crucial factor in tumor growth, it was noted that ovarian cell lines in which constitutive IL-8 expression is elevated did not form tumors. Injection of neutralizing Ab to IL-8 reverted the phenotype and caused tumor growth in vivo. Examination of tissue from the inoculation site revealed a dramatically elevated cellularity, containing neutrophils and macrophages, in mice receiving IL-8-expressing tumor cells. These results suggest that IL-8 production by human ovarian tumor cells can play a role in reducing the rate of tumor growth; this effect may be mediated by the increased targeting of neutrophil and other mononuclear cells to the tumor injection site. These studies indicate a role for IL-8 in ovarian cancer control and suggest that chemotherapy-induced IL-8 may have a positive role in controlling tumor growth.Keywords
This publication has 30 references indexed in Scilit:
- Augmentation of Cancer Chemotherapy by Preinjection of Human Macrophage Colony‐stimulating Factor in L1210 Leukemic Cell‐inoculated MiceJapanese Journal of Cancer Research, 1995
- The role of interleukin 12 in the immune response, disease and therapyImmunology Today, 1994
- Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.Journal of Experimental Medicine, 1994
- Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?Immunology Today, 1994
- Induction of Tumor Necrosis Factor in Mice by Recombinant Human Macrophage Colony‐stimulating FactorJapanese Journal of Cancer Research, 1994
- An Eosinophil-Dependent Mechanism for the Antitumor Effect of Interleukin-4Science, 1992
- Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune responseImmunology Today, 1992
- Properties of the Novel Proinflammatory Supergene "Intercrine" Cytokine FamilyAnnual Review of Immunology, 1991
- Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole bloodBiochemical and Biophysical Research Communications, 1991
- Induction of haptotactic migration of melanoma cells by neutrophil activating protein/interleukin-8Biochemical and Biophysical Research Communications, 1990